Snowball logo
logo
NBIX_logo

Neurocrine Biosciences, Inc

NBIX β€’ NASDAQ
$152.57-$0.36001Β  (0.24%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
1,133.51,488.71,887.12,355.32,860.53,373.9
COGS
14.323.239.73452.168.6
Gross Profit
1,119.21,465.51,847.42,321.32,808.43,305.3
Operating Expenses & Income
Operating Income
102.5249250.9570.5619.1788.9
Total Operating Expenses
1,016.71,216.51,596.51,750.82,189.32,516.4
R&D Expenses
328.1463.8565731.11,015.71,131.1
Selling General & Admin Expenses
583.3752.7851.6816.21,156.21,351.6
Earnings from Continuing Operations
Interest Expense
(25.8)(7.1)(4.6)(126.6)-(2.9)
Interest Income
-4.152.89190.3-
Income Tax Expense
11.859.482.4144.7226.8234.7
Net Income
Net Income
89.6154.5249.7341.3478.6705.5
Supplemental
EBIT
127.2249394.8612.6636.5870.8
EBITDA
138.1264.6416.1639.7666.6918.1
In millions of USD, except % and values per 1 share